# Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis

> **NCT05530291** · — · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 85259 (actual)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **OTHER:** Non-interventional

## Key facts

- **NCT ID:** NCT05530291
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-18
- **Primary completion:** 2022-11-22
- **Final completion:** 2022-11-22
- **Target enrollment:** 85259 (ACTUAL)
- **Last updated:** 2024-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05530291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05530291, "Incidence and Clinical Burden of Erythropoietin Hyporesponsiveness - a Retrospective Database Analysis". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05530291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*